CYFLOX 500 Tablet by Dr Precision is a pharmaceutical-grade oral antibiotic containing 500 mg of Ciprofloxacin, a potent second-generation fluoroquinolone. It is specifically engineered for treating moderate to severe bacterial infections across diverse clinical indications such as complicated urinary tract infections, respiratory tract infections, gastrointestinal infections, skin and soft tissue infections, bone and joint infections, sexually transmitted diseases, and infections caused by multidrug-resistant organisms. Manufactured by BluepillExpress under stringent WHO-GMP, EU-GMP, and USFDA-ready standards, CYFLOX 500 ensures high bioavailability (over 70%), rapid absorption, and excellent tissue penetration into lungs, kidneys, liver, prostate, and bones. The medication acts bactericidally by inhibiting DNA gyrase and topoisomerase IV enzymes, effectively eradicating both gram-positive and gram-negative pathogens, including resistant strains. It is well-suited for hospital step-down therapy and complies with international regulatory documentation for export and institutional supply. Customizable packaging and private-label options make CYFLOX 500 an ideal solution for global pharmaceutical markets requiring reliable, standardized Ciprofloxacin tablets with robust quality assurance and regulatory support.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Ciprofloxacin 500 mg |
| Antibiotic Class | Second-generation fluoroquinolone |
| Therapeutic Use | Treatment of moderate to severe bacterial infections including UTI, respiratory, GI, bone/joint infections, skin infections, and STDs |
| Mechanism of Action | Inhibits bacterial DNA gyrase and topoisomerase IV, leading to bactericidal effect |
| Bioavailability | Over 70%, with rapid absorption and peak plasma concentration within 1-2 hours |
| Tissue Penetration | Extensive distribution to lungs, kidneys, liver, prostate, and bones |
| Pharmacokinetics | Half-life approx. 4 hours; primarily renally excreted |
| Manufacturing Standards | WHO-GMP certified with EU-GMP, PICS, and USFDA-readiness |
| Packaging Options | Customizable Alu-Alu blister, strip packs, HDPE containers |
| Quality Assurance | In-house QA/QC including HPLC assay, dissolution, and stability testing |
| Market Suitability | Ideal for export, institutional supply, private labeling, and bulk manufacturing |
| Attributes | Description |
|---|---|
| Dosage Form | Tablet |
| Strength | 500 mg Ciprofloxacin |
| Administration Route | Oral |
| Indications | Urinary tract infections, respiratory tract infections, gastrointestinal infections, bone and joint infections, skin and soft tissue infections, sexually transmitted diseases, anthrax post-exposure prophylaxis |
| Pharmacokinetics | Bioavailability >70%; peak plasma 1-2 hours; half-life 4 hours; renal excretion |
| Compatibility | Can be co-prescribed with other antibiotics for combined therapy |
| Packaging Type | Alu-Alu blister, blister packs, strip packs, HDPE bottles |
| Stability | Stability data available as per international standards |
| Regulatory Compliance | Manufactured under GMP with EU-GMP, PICS certification and USFDA-ready facilities |
| Custom Services | Private label, bulk manufacturing, batch size flexibility, export documentation including COA, MSDS, MOA |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
CYFLOX 500 tablet contains Ciprofloxacin which has a unique mechanism of action by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and repair. This mechanism is effective even against strains resistant to penicillins and cephalosporins, making it potent against multidrug-resistant organisms.
CYFLOX 500 displays extensive tissue penetration, including into the bones, joints, lungs, and prostate. This broad tissue distribution ensures sufficient drug levels at infection sites such as bone and joint tissue, which is essential for managing osteomyelitis and other deep infections.
CYFLOX 500 is manufactured in WHO-GMP certified facilities with compliance to EU-GMP, PICS guidelines, and USFDA-readiness. It undergoes rigorous in-house QA/QC including HPLC assay, dissolution, and stability tests. Export documentation such as COA, MSDS, MOA, and stability data are provided to meet regulatory requirements globally.
Yes, CYFLOX 500 tablets are available with customizable packaging options like Alu-Alu blister packs, strip packs, and HDPE bottles. The manufacturer offers flexible batch sizes, MOQ-based pricing, and private labeling services tailored for international B2B buyers.
Yes, since Ciprofloxacin is primarily excreted via the kidneys, dose adjustments are recommended for patients with renal impairment to prevent accumulation and adverse effects.
CYFLOX 500 is rapidly absorbed with peak plasma concentrations typically reached within 1 to 2 hours, ensuring prompt antibacterial action.
Country Of Origin: India
CYFLOX 500 Tablet contains Ciprofloxacin 500 mg, a high-strength fluoroquinolone antibiotic used to treat moderate to severe bacterial infections. Manufactured by BluepillExpress under strict international standards, CYFLOX 500 provides powerful antimicrobial action, high bioavailability, and tissue penetration. It is suitable for treatment of complicated urinary tract infections, respiratory tract infections, gastrointestinal infections, and bone/joint infections. With robust quality, global documentation support, and customizable packaging, CYFLOX 500 is ideal for export, institutional supply, and private-label markets.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
CYFLOX 500 Tablet is a pharmaceutical-grade antimicrobial agent formulated with Ciprofloxacin 500 mg, a second-generation fluoroquinolone antibiotic. As an advanced oral treatment option for a wide variety of bacterial infections, it is recognized globally for its rapid action and exceptional therapeutic efficacy against both gram-positive and gram-negative pathogens.
Ciprofloxacin acts by inhibiting two essential bacterial enzymes—DNA gyrase and topoisomerase IV—that are vital for DNA replication, transcription, and repair. This interference results in the disruption of bacterial DNA processes and leads to cell death, making Ciprofloxacin a bactericidal agent. Its mechanism is effective even against bacteria that are resistant to other antibiotic classes like penicillins or cephalosporins.
CYFLOX 500 Tablet is recommended for the treatment of:
Lower and upper urinary tract infections (including pyelonephritis and prostatitis)
Lower respiratory tract infections (chronic bronchitis, pneumonia)
Skin and soft tissue infections (wound infections, cellulitis)
Bone and joint infections (osteomyelitis)
Gastrointestinal infections (infectious diarrhea, typhoid, shigellosis)
Sexually transmitted diseases (gonorrhea)
Infections caused by multidrug-resistant organisms
Anthrax post-exposure prophylaxis (as per CDC guidelines)
This 500 mg strength is particularly suitable for moderate to severe infections or infections that require extended coverage with high serum levels of the drug. It can also serve as a convenient step-down therapy for hospitalized patients transitioning from IV antibiotics to oral dosage.
Pharmacokinetics and Bioavailability
CYFLOX 500 offers excellent oral bioavailability of over 70% and is rapidly absorbed, with peak plasma concentrations reached within 1–2 hours. It has a half-life of approximately 4 hours and demonstrates extensive tissue distribution, including into the lungs, kidneys, liver, prostate, and bones, making it suitable for deep-seated infections.
The drug is excreted primarily via the kidneys, which means dose adjustment is recommended in patients with renal impairment. It may also be co-prescribed with other agents in dual therapy for complicated infections or hospital-acquired cases.
Manufacturing Highlights by BluepillExpress
WHO-GMP certified manufacturing facilities with EU-GMP, PICS, and USFDA-readiness
In-house QA/QC with HPLC assay, dissolution, and stability testing
Customizable packaging (Alu-Alu, blister, strip packs, HDPE)
Export support including COA, MSDS, MOA, stability data, and full dossier
Private labeling and bulk manufacturing services
Batch size flexibility and MOQ-based pricing for international buyers
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
